Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders
申请人:Remenar Julius F.
公开号:US20110166128A1
公开(公告)日:2011-07-07
The present invention provides prodrug compounds of diaryldiazepine drug compounds.
本发明提供了二苯并二氮杂苯类药物化合物的前药化合物。
[EN] CARBACEPHEM BETA-LACTAM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES DE TYPE BÉTA-LACTAME À BASE DE CARBACÉPHÈME
申请人:ACHAOGEN INC
公开号:WO2010030810A1
公开(公告)日:2010-03-18
Carbacephem β-lactam antibiotics having structure (I) are disclosed, including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar2, X, R1 and R2 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.
Carbacephem β-lactam antibiotics having chemical structures (I) and (II) are disclosed: including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar2, R1, R2 and R6 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.
[EN] CARBACEPHEM ß-LACTAM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES BÊTA-LACTAMES À CARBACÉPHÈME
申请人:ACHAOGEN INC
公开号:WO2009055696A1
公开(公告)日:2009-04-30
Carbacephem β-lactam antibiotics having the following chemical structures (I) and (II) are disclosed, including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar2, R1, R2 and R3 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.